NPS Pharmaceuticals Inc. won U.S. approval
for the first drug to treat a rare hormonal abnormality,
vindicating Shire Plc’s gamble to buy the company for $5.2
billion before the outcome was publicly known.
In a report published Tuesday, Barclays Capital analyst Geoffrey Meacham downgraded the rating on NPS Pharmaceuticals (NASDAQ: NPSP) from Overweight to Equal-Weight, and lowered the price target from $50.00 to $46.00.
In the report, Barclays...
NEW YORK (TheStreet) - NPS Pharmaceuticals
shares surged more than 8% on Monday after Dublin's Shire
announced it plans to acquire the Bedminster, N.J.-based biopharmaceutical company for $5.2 billion.
Shire will acquire all outstanding...
Following the market opening Monday, the Dow traded down 0.77 percent to 17,601.64 while the NASDAQ slipped 0.88 percent to 4,662.69. The S&P also fell, dropping 0.93 percent to 2,025.80.
Leading and Lagging Sectors
In trading on Monday,...
NEW YORK (TheStreet) -- NPS Pharmaceuticals
shares are up 8.2% to $45.36 on heavy volume in early market trading today after the company agreed to be bought by Britain's Shire plc
yesterday for $5.2 billion. The purchase price comes to...
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) surged 8.23% to $45.36. The volume of NPS Pharmaceuticals shares traded 9376% higher than normal. Shire PLC (NASDAQ: SHPG) agreed to buy NPS Pharmaceuticals for $5.2 billion, or $46 per share.
In a report published Monday, Jefferies analyst Eun K. Yang reiterated a Hold rating on NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), and raised the price target from $26.00 to $46.00.
In the report, Jefferies noted, “Shire's proposed acquisition...
Analysts at Canaccord Genuity downgraded NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) from Buy to Hold.
The price target for NPS Pharmaceuticals is set to $42.
NPS Pharmaceuticals shares have jumped 19.74% over the past 52 weeks, while the S&P...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday January 9 through Sunday January 11, 2015
Shire to Acquire NPS Pharma for $46.00/Share
Shire plc (NASDAQ: SHPG) and NPS Pharmaceuticals, Inc....
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.